5 research outputs found

    Potential of grass seed production for new lawns

    Get PDF
    The Paspalum and Axonopus genera are among the main warm season grasses used for lawns. The seed propagation contributes to the decrease of the cost of establishment, besides maintaining the exact characteristics of the mother plant genotype, because they are apomictic species. The objective of this work was to evaluate the seed production potential of seventeen grass accesses of the species Paspalum notatum, P. lepton, P. lividum and Axonopus parodii. The experiment was conducted at Capão do Leão, Rio Grande do Sul State, Brazil, in a randomized block design, with four replications. The evaluated variables were: number of inflorescences per area, number of florets per inflorescence and seed production potential (SPP). In order to measure the seed production potential of the accesses, the equation proposed is: SPP = number of florets per inflorescence x number of inflorescences per m2 . There were year, access and interaction between years and accesses effect for the traits number of inflorescences per area and seed production potential. For the number of florets per inflorescence, there was no year effect. Potential production for the 2013/2014 harvest, ranged from 19,152.00 to 135,062.70 seeds m- ², with PN 09 of the P. notatum species standing out. In the 2014/2015 harvest, the seed production potential ranged from 9,973.75 to 81,536.75 seeds m- ², highlighting the access PN 11 of the species P. notatum. The accesses PN 11, PN 09, PN 10 and AP 01 were in the top third of the seed production potential ranking in the two harvests, and “grama-batatais” was in the lower third. There is genotype-environment interaction for all characteristics evaluated. However, there are accesses that show seed production potential consistently superior to the “grama-batatais” control, and have a greater potential for exploitation in the establishment of lawns by seeds

    Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil

    No full text
    Introduction and objectives: Direct antiviral agents (DAAs) including sofosbuvir (SOF), daclatasvir (DCV), simeprevir (SIM) and ombitasvir, paritaprevir and dasabuvir were introduced 2015 in Brazil for treatment of hepatitis C virus (HCV) infection. The aims of this study were to assess effectiveness and safety of HCV treatment with DAA in real-life world in a highly admixed population from Brazil. Materials and methods: All Brazilian reference centers for HCV treatment were invited to take part in a web-based registry, prospectively conducted by the Brazilian Society of Hepatology, to assess outcomes of HCV treatment in Brazil with DAAs. Data to be collected included demographics, disease severity and comorbidities, genotype (GT), viral load, DAA regimens, treatment side effects and sustained virological response (SVR). Results: 3939 patients (60% males, mean age 58 ± 10 years) throughout the country were evaluated. Most had advanced fibrosis or cirrhosis, GT1 and were treated with SOF/DCV or SOF/SIM. Overall SVR rates were higher than 95%. Subjects with decompensated cirrhosis, GT2 and GT3 have lower SVR rates of 85%, 90% and 91%, respectively. Cirrhosis and decompensated cirrhosis in GT1 and male sex and decompensated cirrhosis in GT3 were significantly associated with no SVR. Adverse events (AD) and serious AD occurred in 18% and 5% of those subjects, respectively, but less than 1% of patients required treatment discontinuation. Conclusion: SOF-based DAA regimens are effective and safe in the heterogeneous highly admixed Brazilian population and could remain an option for HCV treatment at least in low-income countries

    Núcleos de Ensino da Unesp: artigos 2013: volume 2: metodologias de ensino e a apropriação de conhecimento pelos alunos

    Get PDF
    Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP

    Núcleos de Ensino da Unesp: artigos 2013: volume 2: metodologias de ensino e a apropriação de conhecimento pelos alunos

    No full text
    Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP
    corecore